Compare MEI & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEI | ENLV |
|---|---|---|
| Founded | 1946 | 2005 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 292.3M | 249.3M |
| IPO Year | N/A | 1995 |
| Metric | MEI | ENLV |
|---|---|---|
| Price | $8.74 | $1.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $11.50 | ★ $13.00 |
| AVG Volume (30 Days) | 359.3K | ★ 466.5K |
| Earning Date | 03-04-2026 | 03-30-2026 |
| Dividend Yield | ★ 2.31% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $984,400,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.66 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.08 | $0.66 |
| 52 Week High | $11.74 | $2.10 |
| Indicator | MEI | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 74.67 | 62.69 |
| Support Level | $7.76 | $1.01 |
| Resistance Level | $8.35 | $1.26 |
| Average True Range (ATR) | 0.42 | 0.09 |
| MACD | 0.12 | 0.01 |
| Stochastic Oscillator | 94.20 | 66.17 |
Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles, including overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.